Previous 10 | Next 10 |
home / stock / bayry / bayry news
In a blow to its hopes of limiting its legal risk around the Roundup weedkiller, Bayer ([[BAYRY]] -1.7%) loses its second appeal of three jury verdicts that found Roundup causes cancer, as a U.S. appeals court refuses to overturn a 2019 $25M judgment and trail verdict in the only case to go t...
Stocks moved another leg higher in April driven by strong earnings, but I am sensing some upcoming cracks due to rising inflation across the board. I am continuing my monthly investment plans while awaiting a market correction or possibly a real crash once market euphoria has come dow...
Bayer Aktiengesellschaft (BAYZF) Q1 2021 Earnings Conference Call May 12, 2021 08:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - CEO Wolfgang Nickl - CFO Liam Condon - President, Crop Science Division Stefan Oelrich - Head, Pharmaceuticals Division Co...
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2021 Q1 earnings call. For further details see: Bayer Aktiengesellschaft 2021 Q1 - Results - Earnings Call Presentation
Risks of increased competition for Eyley are greatly overestimated. Dupixent's prospects are far from being revealed, and its approval in new indications is on the horizon. Libtayo's sales and licensing of the technology platform will also drive revenue growth. For further d...
Mittleman Investment Management, LLC is an SEC-registered investment adviser that provides discretionary portfolio management to institutional investors and high-net-worth individuals. Mittleman Investment Management’s composite gained 25.9% net of fees in the first quarter of ...
More than 40,000 Cancer Claims Remain Unresolved from Proposed Bayer Monsanto Roundup Weed Killer Lawsuit Settlement Many cancer victims critical of settlement structure, vow to pursue jury trials PR Newswire DALLAS , April 26, 2021 /PRNewswire/ -- More ...
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...
After strong momentum during the outbreak of the pandemic, Regeneron has been a laggard. Continued growth is welcomed, yet the firm is not diversified enough to cope with upcoming expirations. The non-demanding valuation should be seen in the light of upcoming expirations, as dive...
A Mexican judge reportedly has issued a favorable ruling in a legal challenge over a government policy that seeks to ban Bayer's (BAYRY) glyphosate, in a temporary reprieve from a looming ban on the herbicide.Mexico's Reforma newspaper reports the judge based his ruling on the risk the ban wo...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...